6098 POSTER CRAFT Trial-Result From Multicenter Phase II Study of Modified FOLFOX7 (Combination Chemotherapy of Infusional 5-FU/l-Leucovorin and Intermittent Oxaliplatin) With Bevacizumab in the First-line Therapy of Colorectal Cancer

2011 ◽  
Vol 47 ◽  
pp. S421
Author(s):  
K. Ishibashi ◽  
K. Koda ◽  
M. Oshiro ◽  
H. Matsuoka ◽  
H. Baba ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Combination Chemotherapy ◽  
Phase Ii Study ◽  
Trial Result ◽  
First Line ◽  
First Line Therapy ◽  
Multicenter Phase ◽  
Line Therapy

scholarly journals Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

Oncology ◽  
2013 ◽  
Vol 85 (1) ◽  
pp. 44-52 ◽  
Author(s):  
Chih-Hung Hsu ◽  
Yoon Koo Kang ◽  
Tsai-Shen Yang ◽  
Chia-Tung Shun ◽  
Yu-Yun Shao ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Hepatocellular Carcinoma ◽  
First Line ◽  
First Line Therapy ◽  
Asian Patients ◽  
Multicenter Phase ◽  
Line Therapy

scholarly journals An Open‐Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX‐6 as First‐Line Therapy for Metastatic Colorectal Cancer

2014 ◽  
Vol 19 (4) ◽  
pp. 350-351 ◽  
Author(s):  
Rocio Garcia‐Carbonero ◽  
Fernando Rivera ◽  
Joan Maurel ◽  
Jean‐Pierre M. Ayoub ◽  
Malcolm J. Moore ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
First Line ◽  
Open Label ◽  
Safety And Efficacy ◽  
First Line Therapy ◽  
Line Therapy ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document